Related references
Note: Only part of the references are listed.Genetics of Resistant Hypertension: a Novel Pharmacogenomics Phenotype
Nihal El Rouby et al.
CURRENT HYPERTENSION REPORTS (2015)
NEDD4-2 and salt-sensitive hypertension
Federica Rizzo et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2015)
TET2 and CSMD1 genes affect SBP response to hydrochlorothiazide in never-treated essential hypertensives
Martina Chittani et al.
JOURNAL OF HYPERTENSION (2015)
Pharmacogenomics of Hypertension: A Genome-Wide, Placebo-Controlled Cross-Over Study, Using Four Classes of Antihypertensive Drugs
Timo P. Hiltunen et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2015)
THERAPY PCSK9 inhibitors for treating familial hypercholesterolaemia
Hiroshi Mabuchi et al.
NATURE REVIEWS ENDOCRINOLOGY (2015)
Heart Disease and Stroke Statistics-2015 Update A Report From the American Heart Association
Dariush Mozaffarian et al.
CIRCULATION (2015)
Is Diabetes Mellitus-Linked Amino Acid Signature Associated With β-Blocker-Induced Impaired Fasting Glucose?
Rhonda M. Cooper-DeHoff et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2014)
G-Protein Receptor Kinase 4 Polymorphism and Response to Antihypertensive Therapy
Anne M. Muskalla et al.
CLINICAL CHEMISTRY (2014)
The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin-Induced Myopathy: 2014 Update
L. B. Ramsey et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
2014 Evidence-based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8) (vol 311, pg 507, 2014)
P. A. James
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Association of Common Polymorphisms in β1-adrenergic Receptor With Antihypertensive Response to Carvedilol
Dayong Si et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2014)
Genetic variation in NEDD4L, an epithelial sodium channel regulator, is associated with cardiovascular disease and cardiovascular death
Jonas Dahlberg et al.
JOURNAL OF HYPERTENSION (2014)
A core promoter variant of angiotensinogen gene and interindividual variation in response to angiotensin-converting enzyme inhibitors
Huimin Yu et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2014)
Blood pressure lowering and cardiovascular risk reply
Johan Sundstrom et al.
LANCET (2014)
Emerging Roles for Pharmacists in Clinical Implementation of Pharmacogenomics
Aniwaa Owusu-Obeng et al.
PHARMACOTHERAPY (2014)
Multilocus Genetic Risk Score Associates With Ischemic Stroke in Case-Control and Prospective Cohort Studies
Rainer Malik et al.
STROKE (2014)
Twelve-Single Nucleotide Polymorphism Genetic Risk Score Identifies Individuals at Increased Risk for Future Atrial Fibrillation and Stroke
Hayato Tada et al.
STROKE (2014)
2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8)
Paul A. James et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
The Role of Plasma Renin Activity, Age, and Race in Selecting Effective Initial Drug Therapy for Hypertension
Gary L. Schwartz et al.
AMERICAN JOURNAL OF HYPERTENSION (2013)
Multilocus Genetic Risk Scores for Coronary Heart Disease Prediction
Andrea Ganna et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Adrenergic Receptor Polymorphisms and Prevention of Ventricular Arrhythmias With Bucindolol in Patients With Chronic Heart Failure
Ryan G. Aleong et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2013)
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update
S. A. Scott et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
2013 ESH/ESC Guidelines for the management of arterial hypertension
Giuseppe Mancia et al.
EUROPEAN HEART JOURNAL (2013)
Loci influencing blood pressure identified using a cardiovascular gene-centric array
Santhi K. Ganesh et al.
HUMAN MOLECULAR GENETICS (2013)
A Blood Pressure Genetic Risk Score Is a Significant Predictor of Incident Cardiovascular Events in 32 669 Individuals
Aki S. Havulinna et al.
HYPERTENSION (2013)
Pharmacogenomic Association of Nonsynonymous SNPs in SIGLEC12, A1BG, and the Selectin Region and Cardiovascular Outcomes
Caitrin W. McDonough et al.
HYPERTENSION (2013)
Genomic Association Analysis of Common Variants Influencing Antihypertensive Response to Hydrochlorothiazide
Stephen T. Turner et al.
HYPERTENSION (2013)
Effects of ACE and ADD1 gene polymorphisms on blood pressure response to hydrochlorothiazide: a meta-analysis
Hye Duck Choi et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2013)
Association of variants in NEDD4L with blood pressure response and adverse cardiovascular outcomes in hypertensive patients treated with thiazide diuretics
Caitrin W. McDonough et al.
JOURNAL OF HYPERTENSION (2013)
S49G and R389G polymorphisms of the β1-adrenergic receptor influence signaling via the cAMP-PKA and ERK pathways
Fan Zhang et al.
PHYSIOLOGICAL GENOMICS (2013)
Pharmacometabolomics Reveals Racial Differences in Response to Atenolol Treatment
William R. Wikoff et al.
PLOS ONE (2013)
Association of chromosome 12 locus with antihypertensive response to hydrochlorothiazide may involve differential YEATS4 expression
J. D. Duarte et al.
PHARMACOGENOMICS JOURNAL (2013)
Prevention of Atrial Fibrillation by Bucindolol Is Dependent on the Beta1389 Arg/Gly Adrenergic Receptor Polymorphism
Ryan G. Aleong et al.
JACC-HEART FAILURE (2013)
Assessment of the value of a genetic risk score in improving the estimation of coronary risk
Carla Lluis-Ganella et al.
ATHEROSCLEROSIS (2012)
Trends in Antihypertensive Medication Use and Blood Pressure Control Among United States Adults With Hypertension The National Health and Nutrition Examination Survey, 2001 to 2010
Qiuping Gu et al.
CIRCULATION (2012)
G Protein Receptor Kinase 4 Polymorphisms β-Blocker Pharmacogenetics and Treatment-Related Outcomes in Hypertension
Alexander G. Vandell et al.
HYPERTENSION (2012)
Association of Angiotensinogen (M235T) Gene Polymorphism with Blood Pressure Lowering Response to Angiotensin Converting Enzyme Inhibitor (Enalapril)
Kamna Srivastava et al.
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2012)
A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010
Stephen S. Lim et al.
LANCET (2012)
Pharmacogenetic Association of NOS3 Variants with Cardiovascular Disease in Patients with Hypertension: The GenHAT Study
Xue Zhang et al.
PLOS ONE (2012)
mRNA Transcript Diversity Creates New Opportunities for Pharmacological Intervention
Elizabeth S. Barrie et al.
MOLECULAR PHARMACOLOGY (2012)
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing
J. A. Johnson et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Cardiovascular Pharmacogenomics of Adrenergic Receptor Signaling: Clinical Implications and Future Directions
J. A. Johnson et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Association of Hypertension Drug Target Genes With Blood Pressure and Hypertension in 86 588 Individuals
Andrew D. Johnson et al.
HYPERTENSION (2011)
A functional variant of the NEDD4L gene is associated with beneficial treatment response with β-blockers and diuretics in hypertensive patients
Patrik Svensson-Farbom et al.
JOURNAL OF HYPERTENSION (2011)
Genetic variation in the renin-angiotensin system, use of renin-angiotensin system inhibitors and the risk of myocardial infarction
Anke-Hilse Maitland-van der Zee et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2011)
Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure
Louise V. Wain et al.
NATURE GENETICS (2011)
Pharmacogenetic Associations of MMP9 and MMP12 Variants with Cardiovascular Disease in Patients with Hypertension
Rikki M. Tanner et al.
PLOS ONE (2011)
Liver X receptor a gene polymorphisms and variable cardiovascular outcomes in patients treated with antihypertensive therapy: results from the INVEST-GENES study
Elvin Tyrone Price et al.
PHARMACOGENETICS AND GENOMICS (2011)
Plasma Renin Activity Predicts Blood Pressure Responses to β-Blocker and Thiazide Diuretic as Monotherapy and Add-On Therapy for Hypertension
Stephen T. Turner et al.
AMERICAN JOURNAL OF HYPERTENSION (2010)
US Trends in Prevalence, Awareness, Treatment, and Control of Hypertension, 1988-2008
Brent M. Egan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Common genetic variations of the renin-angiotensin-aldosterone system and response to acute angiotensin I-converting enzyme inhibition in essential hypertension
Tuula Hannila-Handelberg et al.
JOURNAL OF HYPERTENSION (2010)
Effect of ACE insertion/deletion and 12 other polymorphisms on clinical outcomes and response to treatment in the life study
Borge G. Nordestgaard et al.
PHARMACOGENETICS AND GENOMICS (2010)
G-Protein-Coupled Receintor Kinase 4 Polymorphisms and Blood Pressure Response to Metoprolol Among African Americans: Sex-Specificity and Interactions
Vibha Bhatnagar et al.
AMERICAN JOURNAL OF HYPERTENSION (2009)
Hydrochlorothiazide and Atenolol Combination Antihypertensive Therapy: Effects of Drug Initiation Order
J. A. Johnson et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Follow-up of a major linkage peak on chromosome 1 reveals suggestive QTLs associated with essential hypertension: GenNet study
Georg B. Ehret et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2009)
A Functional Variant of NEDD4L Is Associated With Hypertension, Antihypertensive Response, and Orthostatic Hypotension
Fang Luo et al.
HYPERTENSION (2009)
Interaction between the Gly460Trp alpha-adducin gene variant and diuretics on the risk of myocardial infarction
Diane B. M. A. van Wieren-de Wijer et al.
JOURNAL OF HYPERTENSION (2009)
Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
NEW ENGLAND JOURNAL OF MEDICINE (2009)
α-Adducin polymorphism associated with increased risk of adverse cardiovascular outcomes:: Results from GENEtic Substudy of the INternational VErapamil SR-trandolapril STudy (INVEST-GENES)
Tobias Gerhard et al.
AMERICAN HEART JOURNAL (2008)
beta 1- and beta 2-adrenergic receptor gene beta-blocker use and risk of myocardial infarction and stroke
Rozenn N. Lemaitre et al.
AMERICAN JOURNAL OF HYPERTENSION (2008)
β-Adrenergic Receptor Gene Polymorphisms and β-Blocker Treatment Outcomes in Hypertension
M. A. Pacanowski et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Genomic association analysis suggests chromosome 12 locus influencing antihypertensive response to thiazide diuretic
Stephen T. Turner et al.
HYPERTENSION (2008)
Pharmacogenetic association of the NPPA T2238C genetic variant with cardiovascular disease outcomes in patients with hypertension
Amy I. Lynch et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Global burden of blood-pressure-related disease, 2001
Carlene M. M. Lawes et al.
LANCET (2008)
Treatment of hypertension in patients 80 years of age or older
Nigel S. Beckett et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Interaction between polymorphisms in the renin-angiotensin-system and angiotensin-converting enzyme inhibitor or β-blocker use and the risk of myocardial infarction and stroke
H. Schelleman et al.
PHARMACOGENOMICS JOURNAL (2008)
KCNMB1 genotype influences response to verapamil SIR and adverse outcomes in the INternational VErapamil SR/Trandolapril STudy (INVEST)
Amber L. Beitelshees et al.
PHARMACOGENETICS AND GENOMICS (2007)
Choice of first antihypertensive: Simple as ABCD?
Azra Mahmud et al.
AMERICAN JOURNAL OF HYPERTENSION (2007)
Polymorphism in NEDD4L Is Associated with Increased Salt Sensitivity, Reduced Levels of P-renin and Increased Levels of Nt-proANP
Jonas Dahlberg et al.
PLOS ONE (2007)
Antihypertensive therapy, the α-adducin polymorphism, and cardiovascular disease in high-risk hypertensive persons:: the Genetics of Hypertension-Associated Treatment Study
B. R. Davis et al.
PHARMACOGENOMICS JOURNAL (2007)
A polymorphism within a conserved β1-adrenergic receptor motif alters cardiac function and β-blocker response in human heart failure
Stephen B. Liggett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The influence of the alpha-adducin G460W polymorphism and angiotensinogen M235T polymorphism on antihypertensive medication and blood pressure
Hedi Schelleman et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2006)
β1-adrenergic receptor polymorphisms influence the response to metoprolol monotherapy in patients with essential hypertension
Jie Liu et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Hydrochlorothiazide efficacy and polymorphisms in ACE, ADD1 and GNB3 in healthy, male volunteers
SV Vormfelde et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Interactions between five candidate genes and antihypertensive drug therapy on blood pressure
H Schelleman et al.
PHARMACOGENOMICS JOURNAL (2006)
Association of NEDD4L ubiquitin ligase with essential hypertension
CJ Russo et al.
HYPERTENSION (2005)
Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease
CY Hsu et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Angiotensinogen gene polymorphisms: Relationship to blood pressure response to antihypertensive treatment
L Kurland et al.
AMERICAN JOURNAL OF HYPERTENSION (2004)
The thiazide-sensitive Na+-Cl- cotransporter gene, C1784T, and adrenergic receptor-β3 gene, T727C, may be gene polymorphisms susceptible to the antihypertensive effect of thiazide diuretics
T Matayoshi et al.
HYPERTENSION RESEARCH (2004)
Beta1-adrenergic receptor gene polymorphisms and response to betal1-adrenergic receptor blockade in patients with essential hypertension
J Karlsson et al.
CLINICAL CARDIOLOGY (2004)
Effects of endothelial nitric oxide synthase, α-adducin, and other candidate gene polymorphisms on blood pressure response to hydrochlorothiazide
ST Turner et al.
AMERICAN JOURNAL OF HYPERTENSION (2003)
Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000
I Hajjar et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
β1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol
JA Johnson et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure - The JNC 7 Report
AV Chobanian et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
ACE and α-adducin polymorphism as markers of individual response to diuretic therapy
MT Sciarrone et al.
HYPERTENSION (2003)
Diuretic therapy, the α-adducin gene variant, and the risk of myocardial infarction or stroke in persons with treated hypertension
BM Psaty et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
α-adducin 460Trp allele is associated with erythrocyte Na transport rate in North Sardinian primary hypertensives
N Glorioso et al.
HYPERTENSION (2002)
C825T polymorphism of the G protein β3-subunit and antihypertensive response to a thiazide diuretic
ST Turner et al.
HYPERTENSION (2001)
Share Paper
